United Way hosts diaper drive to aid families in need
GREENFIELD, Mass. (WWLP) – United Way of the Franklin & Hampshire Region (UWFH) is sponsoring a diaper drive for families in need through June 30.
SNAP and WIC cannot be used to buy diapers, and can cost as much as $100 per month per child, with prices continuing to rise. In a study conducted by researchers at the University of Vermont and the Greater Boston Food Bank, around 36% of Massachusetts families with young children could not afford enough diapers for their children.
Youth in Springfield showcase mental health in photo exhibit
UWFH is looking to collect 20,000 diapers to distribute to 14 local agencies in their service area for families in need. While they accept all brands and sizes, donors are asked to give larger diaper sizes for children that are often harder to come by at local pantries, specifically sizes 4, 5, and 6, as well as pull-up training pants.
There will be a standout on Saturday, June 21, from 10:30 a.m. to 12:30 p.m. at Stop & Shop in Northampton and Saturday, June 28, from 10 a.m. to 12 p.m. at Stop & Shop in Greenfield, where donations will be accepted.
Greenfield Savings Bank is sponsoring the diaper driver and is matching all monetary donations up to $10,000. Online donations can be made uw-fh.org/diaper-drive.
WWLP-22News, an NBC affiliate, began broadcasting in March 1953 to provide local news, network, syndicated, and local programming to western Massachusetts. Watch the 22News Digital Edition weekdays at 4 p.m. on WWLP.com.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
17 hours ago
- CBS News
Murkowski says she has been "pretty clear" about her concerns with Trump's "big, beautiful bill"
Republican Sen. Lisa Murkowski says she has been "pretty clear" about her concerns over potential cuts President Trump's so-called "big, beautiful bill" would make to Medicaid and food benefits for her constituents in Alaska. In an interview for "CBS Sunday Morning," Murkowski told CBS News senior correspondent Norah O'Donnell that she hasn't given any absolute deal-breakers in the Senate legislation — but she's voiced her reservations about the Medicaid proposals. "I have not given anybody in the administration an absolute, this is my red line, right?" Because I think it's important that every step of the way, I communicate where my concerns are," Murkowski told O'Donnell in the interview airing this weekend. The reconciliation bill — or "one big, beautiful bill," as Mr. Trump and Republicans in Congress have dubbed it — has passed the House, but remains up for debate in the Senate, where some Republicans are pushing for deeper cuts to Medicaid than the House-passed version allows. Medicaid is the entitlement program that offers government-backed health care for both low-income Americans and those with disabilities, with the federal government and states splitting the costs. While the House version adds a new work requirement to Medicaid for childless adults, the Senate wants work requirements to expand to parents of older children. The Supplemental Nutrition Assistance Program, or SNAP, provides food benefits to the poorest Americans, and some Senate Republicans are hoping to place more requirements on states. "So I've been pretty clear that when it comes to Medicaid, those cuts that would harm Alaskan beneficiaries, that's not something that I can take home, right? We have some of the highest health care costs in the country. We have 40% of Alaska's kids that are on Medicaid. I want to try to do what we can to address certain aspects of our entitlement spending. We've got to do that. But doing it with the most vulnerable bearing the brunt of that is not the answer," she said. Senate Majority Leader John Thune, a Republican from North Dakota, wants the reconciliation bill to pass by the July 4 holiday, but that deadline is quickly approaching. Watch more of the interview with Sen. Lisa Murkowski on "CBS Sunday Morning" on Sunday, June 22.
Yahoo
3 days ago
- Yahoo
Morgan Stanley Bets on These 2 Managed Care Stocks Despite Policy Uncertainty
A major shift in U.S. social policy may be underway. The Republican-led Congress and White House are advancing a new tax bill that reflects a stark departure from the previous administration's approach. Central to the legislation are deep cuts – amounting to roughly $1 trillion – to key welfare programs like Medicaid and SNAP (Supplemental Nutrition Assistance Program). Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter These entitlement programs have traditionally been considered politically off-limits, but the current majority's willingness to target them signals a broader agenda and raises the prospect of continued policy uncertainty. Despite this uncertain future for the important Medicaid program, Morgan Stanley sees an interesting opportunity for investors in care stocks. The bank's analysis team, led by Erin Wright, an analyst ranked among the top 3% of Wall Street's stock experts, says of the managed care sector: 'We see manageable policy risk, opportunities across D-SNP and ICHRA, and capital deployment supporting +HSD to LDD long-term EPS growth. While policy risk remains in undefined government funding reductions, we view the outcome of preliminary slated Medicaid cuts to be better than feared and this overhang to be disproportionately reflected in the stocks.' Putting that stance into practice, Wright goes on to recommend two specific stocks in the managed care segment. We've used the TipRanks data platform to look up the general Wall Street view of them, and found that both hold Buy ratings and offer double-digit upside potential. Here are the details, and the Morgan Stanley comments. Centene Corporation (CNC) Centene, the first company we'll look at here, has more than 40 years' experience as a managed care insurance provider in the US healthcare industry. The company offers a wide variety of coverage plans in the private health insurance market, ranging from lower-cost affordable plans to higher-end premium offerings – and the company also acts as a provider for government-backed plans, in Medicaid and Medicare programs, as well as military and veterans' services. The numbers show the scale of Centene's operations – and the company's status as one of the major players in the US health insurance scene. Centene boasts a market cap of $27 billion, and employs more than 60,000 people. The company has more than 27.9 million managed care members enrolled in its plans, and boasts that it provides coverage for more than 1 in every 15 people across all 50 states. Specifically, Centene is the largest managed care Medicaid provider in the US, and holds leading positions in three of the leading state markets for Medicaid: Florida, New York, and Texas. Centene also claims to be the 'number one' health insurance carrier on the Health Insurance Marketplace, the exchange originally set up under the Affordable Care Act. The market uncertainties, especially those related to the Republicans' attitude toward health and welfare entitlements, have put pressure on CNC shares this year, and the stock is down approximately 10% for the year-to-date. While the stock is down, however, the company put in a strong display in its last set of reported financial results, covering 1Q25. Membership in the quarter was up 29% year-over-year in the Marketplace, and grew by 22% in Medicare PDP. At the top line, Centene's revenue gained 15% compared to 1Q24, to reach $46.62 billion, and beat the forecast by $3.37 billion. The company reported a bottom line of $2.90 per share, by non-GAAP measures, a figure that was 38 cents per share better than had been anticipated. Turning to Erin Wright, and the Morgan Stanley view, we find that she is impressed by Centene's strong position, which gives the company a sound foundation for future growth in an expanding health insurance niche. The 5-star analyst writes, 'Based on our proprietary analysis, with impending D-SNP integration requirements slated in 2027 and 2030, we view CNC as well-poised for outsized growth in D-SNP (+10% 5-year CAGR), an inherently higher margin segment and a dynamic that is likely overlooked by investors. Faster growth across higher margin segments along with continuing cost savings / S&A leverage should support margin expansion over time. These drivers, along with capital deployment, should support EPS CAGR of +8.8% over the next three years, slightly ahead of Consensus (+8.6%)…' These comments back up the analyst's Overweight (i.e., Buy) rating on this stock, while her $70 price target implies a potential upside for the year ahead of 27%. (To watch Wright's track record, click here) The Moderate Buy consensus rating on CNC is based on 12 recent analyst reviews, that include 7 to Buy and 5 to Hold. The shares are currently trading for $54.68 and their $73.60 average price target points toward a gain of 34.5% in the next 12 months. (See CNC stock forecast) Molina Healthcare (MOH) Next on our list, Molina Healthcare, is another multi-billion health insurance provider, with a focus on offering plans through Medicaid and Medicare. The company has been in business since 1980, and today has a market cap of nearly $16 billion. Molina's plans cover a variety of services, starting with primary care and prescription drugs, but also including specialist care, mental health services, vision and dental plans, and even medical transportation. Molina Healthcare is based in Long Beach, California, where it was founded by an emergency room physician. The company's original goal, still relevant today, was to 'fill the gap,' and provide coverage for indigent and low-income patients who would otherwise have to use ER facilities for routine medical procedures. Today, in addition to providing managed care services under Medicare and Medicaid, Molina also operates as an HMO and provides plans through the various state health insurance exchanges. As of this past March 31, the end of 1Q25, Molina had approximately 5.8 million members enrolled. Molina's large enrollment numbers are a solid asset, and translate to sound financial results. In 1Q25, the last period reported, the company's total revenue came to $11.15 billion, a figure that was up more than 12% year-over-year and beat the estimates by $340 million. This revenue performance was backed by strong earnings; the company reported a non-GAAP EPS of $6.08, beating the forecast by 12 cents per share. When we check in again with Morgan Stanley's Erin Wright, we find the top-rated analyst impressed by Molina's prospects. Outlining everything, with particular attention to the company's probable ability to expand revenue growth, Wright says, 'We view MOH as well-positioned for faster than market premium revenue growth with continuing high contract retention rates, where it boasts a successful track record, new contract procurements (MSe +$3.5B in 2025+), and compelling opportunities in D-SNP alignment, helping to fuel an estimated +7.2% organic premium revenue CAGR over the next 3 years, with MSe $8.65/sh embedded earnings power in 2026+. Durable industry leading margins and buybacks (~2% annually) should drive MSe +12.7% EPS CAGR over the next three years (Cons. +12.8%). Consistent with past practices, M&A should also further supplement growth.' Wright puts an Overweight (i.e., Buy) rating on Molina's stock, which she complements with a $364 price target that suggests an upside for the coming year of 25.5%. Turning now to the overall Street view on MOH, the stock has 11 recent reviews, including 7 Buys, 3 Holds, and 1 Sell, backing up its Moderate Buy consensus rating. The stock's $290.25 trading price and $370.60 average target price together imply that the shares will gain 27.5% on the one-year horizon. (See MOH stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment. Disclaimer & DisclosureReport an Issue Sign in to access your portfolio
Yahoo
4 days ago
- Yahoo
Medela Introduces Pump In Style® Pro: Hospital-Grade Innovation Designed for Real Life
The new pump blends clinically proven performance with modern convenience, offering moms reliable support and continuity of care from hospital to home Pump In Style® Pro Pump In Style® Pro McHenry, Illinois, June 17, 2025 (GLOBE NEWSWIRE) -- Medela, the brand trusted by millions of moms worldwide and the #1 brand in hospitals1, today announced the launch of the Pump In Style® Pro, the latest evolution in its trusted product line. Developed from five years of insights and feedback, the new and improved Pump In Style® Pro delivers hospital-grade performance in a compact, easy-to-use design, offering moms seamless continuity of care from hospital to home. To develop the most efficacious pump on the market, Medela grounded its approach in research combining clinical evidence with real-world insights. Input from hundreds of healthcare professionals, its community of moms, quantitative survey research and focus group shaped every step of the process. By addressing common pain points and pitfalls associated with other pumps, Medela designed a solution that features a clinically proven pumping pattern modeled after the #1 breast pump used in hospitals, the Medela Symphony®. The result is a pump that empowers moms to express milk more effectively and confidently at home. 'At Medela, we understand that every mom's breastfeeding journey has many stages and the adjustment from hospital to home can be challenging and stressful without the right support. Our goal is to make that transition as seamless as possible with the new Pump In Style Pro®,' said Kelley Evans, EVP and Head of Commercial, Americas, at Medela. 'This redesigned pump combines the power of our hospital-grade technology with a design that's simple, comfortable, and built for everyday life.' Key features of the new Pump In Style® Pro include: Hospital-Grade Performance at Home: Features a clinically proven pumping pattern, similar to Medela's hospital pump Symphony, for effective milk expression, more comfort and a stress-free transition home. Pumping Level & Mode Indicators: 16 level indicators and pumping mode indicators allow moms to fine tune their comfort and take control of each pumping session. Lightweight & Compact: Weighs less than 2 pounds, making it easy to transport and ideal for use on the go. 11.8%2 More Milk: Clinically Proven Breast Shield Technology to increase milk volume. Closed System & Easy Cleaning: Dishwasher safe parts and backflow protector. The Pump In Style® Pro is now available through insurance and WIC. For more information on coverage and purchasing options, please see here. Additional downloadable materials, including a factsheet, visual assets, and video content, are available via the Medela media portal. About MedelaThrough advancing research, observing natural behavior and listening to our customers, Medela turns science into care while nurturing health for generations. Medela supports millions of moms, babies, patients and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela provides leading research-based breast milk feeding products, healthcare solutions for hospitals, and clinical education. Medela is dedicated to building better health outcomes, simplifying and improving life, and developing breakthroughs that help moms, babies and patients live their life to the fullest. For more information, visit (1) Sales and distribution in maternity wards and NICUs, 2023 & 2024 (2) Sakalidis VS, et al. Breast shield design impacts milk removal dynamics during pumping: A randomized controlled non-inferiority trial. Acta Obstet Gynecol Scand. 2020. Attachments Pump In Style® Pro Pump In Style® Pro CONTACT: medela@
